…
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-01-01 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-01-01 |
| Income before tax | 217.73M | 208.00M | 355.44M | 225.30M | - |
| Minority interest | - | 0.00M | -0.10M | 0.80M | - |
| Net income | 190.77M | 164.70M | 321.52M | 199.60M | - |
| Selling general administrative | 695.30M | 265.20M | 179.90M | 212.90M | - |
| Selling and marketing expenses | - | 449.90M | 475.00M | 415.50M | - |
| Gross profit | 1026.51M | 1165.40M | 1122.22M | 954.50M | - |
| Reconciled depreciation | 148.80M | 156.20M | 149.00M | 142.50M | - |
| Ebit | 365.52M | 384.38M | 411.60M | 223.70M | 206.70M |
| Ebitda | 520.38M | 483.45M | 560.60M | 381.20M | - |
| Depreciation and amortization | 154.87M | 99.08M | 149.00M | 157.50M | - |
| Operating income | 365.52M | 234.70M | 392.20M | 223.70M | - |
| Other operating expenses | 3741.78M | 3605.00M | 5033.20M | 5417.80M | 0.80M |
| Interest expense | 33.10M | 29.77M | 19.20M | 19.30M | 0.00M |
| Tax provision | 25.90M | 43.30M | 44.70M | 25.70M | - |
| Interest income | 2.40M | 5.40M | 9.60M | 1.70M | - |
| Net interest income | -29.40M | -26.80M | -12.50M | -20.80M | - |
| Income tax expense | 26.96M | 43.30M | 40.49M | 25.70M | 17.00M |
| Total revenue | 4107.29M | 3839.70M | 5018.33M | 5642.40M | - |
| Total operating expenses | 660.99M | 930.70M | 731.90M | 729.90M | - |
| Cost of revenue | 3080.78M | 2674.30M | 3896.12M | 4687.90M | - |
| Total other income expense net | -147.79M | -26.70M | -36.76M | 1.60M | - |
| Discontinued operations | - | - | - | 57.20M | 26.40M |
| Net income from continuing ops | 183.30M | 164.70M | 347.70M | 199.60M | - |
| Net income applicable to common shares | - | - | - | 257.60M | 167.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-01-01 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-01-01 |
| Total assets | 3974.47M | 3874.50M | 3571.18M | 3860.10M | - |
| Intangible assets | 670.38M | 770.90M | 809.90M | 783.80M | - |
| Other current assets | 0.10M | 74.80M | 64.39M | 409.60M | 236.20M |
| Total liab | 2047.04M | 1801.70M | 1640.61M | 1991.70M | - |
| Total stockholder equity | 1927.43M | 2072.80M | 1930.57M | 1861.10M | - |
| Deferred long term liab | - | - | - | 22.40M | 22.20M |
| Other current liab | 106.81M | 286.40M | 410.38M | 69.20M | 65.90M |
| Common stock | 18.40M | 18.73M | 19.80M | 104.10M | 17.20M |
| Capital stock | 18.40M | 19.40M | 19.80M | 104.10M | - |
| Retained earnings | 1743.81M | 1775.20M | 1830.80M | 1397.70M | 1381.70M |
| Other liab | - | - | - | 134.90M | 197.70M |
| Good will | 863.30M | 837.10M | 727.40M | 668.30M | - |
| Other assets | - | - | -227.92M | 91.90M | 73.80M |
| Cash | 491.26M | 417.00M | 413.70M | 438.60M | - |
| Total current liabilities | 1218.95M | 1054.50M | 880.50M | 1120.00M | 887.40M |
| Current deferred revenue | - | - | -282.08M | - | - |
| Net debt | 722.59M | 541.90M | 358.10M | 574.20M | - |
| Short term debt | 396.15M | 321.60M | 129.00M | 276.00M | - |
| Short long term debt | 375.60M | 300.80M | 108.90M | 258.20M | - |
| Short long term debt total | 1213.84M | 958.90M | 771.80M | 1012.80M | - |
| Other stockholder equity | 90.41M | 278.87M | 79.97M | 359.30M | 251.90M |
| Property plant equipment | - | - | - | 573.30M | 585.10M |
| Total current assets | 1652.50M | 1487.10M | 1483.10M | 1551.90M | 1429.00M |
| Net tangible assets | - | - | - | 431.40M | 379.00M |
| Short term investments | - | - | 15.25M | - | - |
| Net receivables | 498.16M | 360.50M | 445.39M | 379.50M | 352.40M |
| Long term debt | 641.60M | 552.20M | 553.50M | 639.80M | - |
| Inventory | 662.98M | 634.80M | 550.20M | 703.70M | 593.60M |
| Accounts payable | 715.99M | 344.60M | 280.20M | 774.80M | 442.50M |
| Accumulated other comprehensive income | 74.81M | - | 189.86M | - | - |
| Non currrent assets other | 16.20M | -114.38M | 28.74M | 278.10M | - |
| Non current assets total | 2321.98M | 2387.40M | 2316.00M | 2308.20M | - |
| Capital lease obligations | 108.50M | 105.90M | 109.40M | 114.80M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-01-01 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-01-01 |
| Investments | 1.80M | -375.00M | 84.00M | 176.70M | 1.00M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -78.89M | -375.00M | 84.00M | 176.70M | -147.30M |
| Net borrowings | 87.20M | -0.50M | -130.80M | -108.90M | 56.00M |
| Total cash from financing activities | -315.04M | -258.40M | -366.57M | -390.20M | -118.30M |
| Change to operating activities | - | - | - | 38.00M | 202.00M |
| Net income | 190.77M | 164.70M | 321.52M | 256.80M | 167.00M |
| Change in cash | 18.25M | -188.60M | 112.30M | 85.90M | 2.90M |
| Begin period cash flow | 473.01M | 304.80M | 192.50M | 94.50M | 94.50M |
| End period cash flow | 491.26M | 116.20M | 304.80M | 180.40M | 94.50M |
| Total cash from operating activities | 396.53M | 443.20M | 425.30M | 298.30M | 251.10M |
| Issuance of capital stock | - | - | - | 0.00M | - |
| Depreciation | 154.87M | 156.20M | 149.00M | 142.50M | 102.20M |
| Other cashflows from investing activities | - | -25.10M | 74.41M | -11.70M | 23.20M |
| Dividends paid | 122.60M | 104.40M | 97.20M | 84.40M | 80.50M |
| Change to inventory | -7.39M | -121.50M | 176.85M | -101.10M | -186.10M |
| Change to account receivables | -62.97M | 116.00M | -84.26M | 5.60M | -13.40M |
| Sale purchase of stock | -258.94M | -129.80M | -148.10M | -196.90M | - |
| Other cashflows from financing activities | -24.25M | -23.70M | 15.24M | 671.90M | - |
| Change to netincome | - | - | - | -44.30M | -45.30M |
| Capital expenditures | 51.62M | 87.10M | 68.63M | 68.90M | 49.50M |
| Change in working capital | -13.22M | -61.30M | -44.12M | -57.50M | - |
| Stock based compensation | 21.90M | 18.20M | 24.50M | 18.80M | - |
| Other non cash items | 64.11M | 165.40M | -25.60M | -62.30M | - |
| Free cash flow | 344.91M | 356.10M | 356.67M | 229.40M | - |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| GLB Glanbia plc |
-0.80 3.85% |
20.00 | 0.28 | 12.38 | 1.08 | 2.44 | 1.36 | 13.84 |
| ABF Associated British Foods PLC |
-39.00 1.98% |
1927.00 | 13.37 | 12.18 | 0.69 | 1.21 | 0.82 | 6.04 |
| KYGA Kerry Group |
-0.80 0.82% |
97.00 | 0.17 | 13.30 | 1.60 | 1.85 | 1.94 | 11.32 |
| MICC The Magnum Ice Cream Company N.V. |
-1.00 0.07% |
1449.00 | 25.07 | 13.30 | 0.82 | 12.11 | 1.31 | 11.19 |
| CWK Cranswick PLC |
-60.00 1.13% |
5260.00 | 19.74 | 17.06 | 1.00 | 2.75 | 1.03 | 9.56 |
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
| Name | Title | Year Born |
|---|---|---|
| Dr. Peter Michael Yu Ph.D. | Chairman & CEO | 1961 |
| Mr. Gregory R. Armstrong | CFO & Director | 1977 |
| Mr. Hugh McGuire Dip Finance, M.Sc | CEO & Executive Director | 1971 |
| Mr. Mark A. Garvey | CFO & Executive Director | 1964 |
| Mr. Liam Hennigan | Group Secretary & Head of Investor Relations | NA |
| Mr. Ian Doyle | Chief Corporate Development Officer | 1978 |
| Mr. Tom Tench | CEO Dairy Nutrition | 1971 |
| Ms. Wendy Smith | Chief Digital & Transformation Officer | NA |
| Ms. Sorcha McKenna | Chief Strategy Officer | NA |
| Mr. Steve Waters | Chief Supply Chain Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.